Results 161 to 170 of about 381,135 (230)

Scoping review about pathogenesis, risk factors, and treatment of venous and arterial thrombosis in coronavirus infection. [PDF]

Front Cardiovasc Med
Malaeb D, Mansour S, Dia N, Kassem NM, Haddad C, Dabbous M, Ismail O, Adel F, Gamal M, Lucca JM, El Khatib S, Salameh P, Hallit S, Hosseini H.   +13 more
europepmc   +1 more source

Low-Molecular-Weight Heparin Plus Insulin in Hypertriglyceridemic Acute Pancreatitis: A Randomized Clinical Trial.

JAMA Netw Open
He W, Ding L, Liu Z, Hua M, Zhou Y, Gong M, Sheng J, Wu X, Fan H, Shu H, Wang R, Xun L, Huang C, Guo F, Cao C, Zhan Z, Chen H, Qian X, Liu Q, Li Q, Tang Z, Xiong Y, Xie P, Yu B, Wan J, Ke H, Wu Y, Hu Y, Ai J, Huang X, Lei Y, Xiong H, Liu Z, Zhu Y, Luo L, Xia L, Ke L, Cai W, Huang W, Li W, Windsor J, Sutton R, Lv N, Zhu Y, Chinese Acute Pancreatitis Clinical Trials Group (CAPCTG).   +44 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Heparin/Low-molecular-weight-heparins

Reactions Weekly
semanticscholar   +6 more sources

Heparin/Low-molecular-weight-heparins

Reactions Weekly, 2019
semanticscholar   +4 more sources

Heparin/low molecular weight heparin

Reactions Weekly, 2018
openaire   +2 more sources

Low molecular weight heparins

Expert Opinion on Pharmacotherapy, 2000
Since its discovery, nearly 90 years, heparin has been used successfully for the treatment of thromboembolic processes. However, therapy with heparin has several important limitations. Most importantly, the poor predictability of its anticoagulant effects has led to the development of the low molecular weight heparins (LMWHs), which are derived from ...
O M, Aguilar, N S, Kleiman
openaire   +3 more sources

Low molecular weight heparins

Current Opinion in Cardiology, 1994
Low molecular weight heparins are derived from unfractionated heparin by chemical or enzymatic depolymerization; as a result, the mean molecular weight of unfractionated heparin is reduced by about one third and its biochemical and pharmacologic properties are improved.
B, Cosmi, J, Hirsh
openaire   +2 more sources

Heparin and low-molecular-weight heparin

Thrombosis and Haemostasis, 2008
SummaryHeparin is one of the oldest biological medicines, and has an established place in the prevention and treatment of venous thrombosis. Low-molecular-weight heparins (LMWH) have been developed by several manufacturers and have advantages in terms of pharmacokinetics and convenience of administration.
Elaine, Gray, Barbara, Mulloy, Trevor W, Barrowcliffe   +2 more
openaire   +2 more sources